At #SCOPESummit, @panalgoinsights and @MMITNetwork experts will be onsite to show you how integrated RWD and AI-enabled analytics can bridge the gap—supporting smarter decisions from strategy to commercialization. Schedule a meeting with us at @SCOPE_365: https://t.co/2u7SSpJwut

Breaking down international data barriers has been a long-standing challenge for life sciences companies. In this blog post, ErikMaul, Senior Director of RWE Partnerships at Panalgo, shares how IHD Cloud is changing the game. https://t.co/FmJNuYD601

From infectious diseases to rare genetic disorders, #RWE is reshaping regulatory decisions. Explore 8 FDA-recognized success stories in our latest booklet. Download now: https://t.co/XpcIsucEOC.

Can COVID-19 during pregnancy impact delivery outcomes? @panalgoinsights’s Mike Munsell, PHD, shares how our mother-infant linked data uncovers real-world insights into maternal and child health. Read the full story in @DrugDiscoverDev: https://t.co/FHzqXs1RGz

The line between clinical and RWE is blurring. Recent FDA guidance makes it clear: RWE is becoming regulatory-grade evidence. Our booklet highlights 8 real-world cases where RWE drove approvals and label expansions—from vaccines to rare diseases. https://t.co/QhFfD0L3OL.

Early evidence is now essential. With @panalgoinsights’s real-world data & analytics, teams can gauge disease burden, pinpoint high-value endpoints, and design stronger trials—before the first patient enrolls. Meet us at @SCOPE_365: https://t.co/sllKuihkK9 #SCOPESummit

From preterm birth risks to lung cancer outcomes, RWD is changing what we know about patient care. @panalgoinsights’s Mike Munsell, PHD, spoke with @DrugDiscoverDev about two new studies presented at ICPE: https://t.co/fzI9I3wm0h Explore the findings at the link in this post.

We spoke with Erik Maul, Senior Director of RWE Partnerships at Panalgo, to learn how IHD Cloud enables companies to access international data silos without physically moving data, thereby accelerating insights and reducing costs. https://t.co/u7WjbaDLMw

In our new booklet, you’ll see how manufacturers used #RWD to achieve FDA approvals for life-changing rare-disease therapies. https://t.co/APHfZ90NwB Download the booklet now and explore 8 FDA-recognized RWE cases.

From vaccines to gene therapies, leading manufacturers are using #RWD to speed approvals and expand indications. Get 8 FDA-recognized RWE approval cases in our new booklet. https://t.co/s7Vq0xsBa1 Download today and learn how leading manufacturers use RWD.

See Panalgo’s RWE solutions in action. This collection of real-world case studies explores how Panalgo’s IHD platform, real-world data, and evidence generation services are being leveraged in the industry. Download today: https://t.co/9OevoXCD2g

From HEOR to Market Access, Medical Affairs to Epidemiology, Ella helps you move from concept to insight—fast. Learn more: https://t.co/VZMb8YjZ8n

From preterm birth risks to lung cancer outcomes, RWD is changing what we know about patient care. @panalgoinsights’s Mike Munsell, PHD, spoke with @DrugDiscoverDev about two new studies presented at ICPE: https://t.co/wx3IHCXYrF Explore the findings at the link in this post.

“Ella, I have a publication deadline. Can you help?” Ella delivers a fully packaged, audit-ready IHD project—complete with a structured analytic dataset, built-in documentation, and ready-to-use visual outputs. What will you ask Ella? https://t.co/hCyaDmqxMo

In https://t.co/elhCN3seYi, Andrew Goldstein and Niyati Parikh discuss how pharma leaders can ensure the ethical, transparent use of RWD with AI—and avoid the risks of misuse. https://t.co/wKWqlRgPUY

"Ella, which dataset do you recommend?” Ella, our genAI assistant, reviews your study concept and suggests the most relevant datasets—whether from your own sources or NorstellaLinQ’s 74 billion+ linked and tokenized data points. What will you ask Ella? https://t.co/9TP6xznjS9

What happens when you have the right data, the right tools, and the right partner? Find out in this booklet of eight real-world case studies showing how organizations are leveraging Panalgo’s RWE solutions. Download the booklet: https://t.co/cSEsehBfsk

Ella, Panalgo's GenAI assistant, instantly guides you through selecting clinical criteria, inclusion and exclusion logic, and demographic filters with simple, conversational prompts to build your cohort. What will you ask Ella? https://t.co/6FbaXo07L6

How are leading organizations using Panalgo's solutions to drive impact with RWE? Find out with this booklet of eight case studies showing the power of real-world data, advanced analytics, and expert services. Download the booklet today: https://t.co/SHXBjz4uzV

From preterm birth risks to lung cancer outcomes, RWD is changing what we know about patient care. @panalgoinsights’s Mike Munsell, PHD, spoke with @DrugDiscoverDev about two new studies presented at ICPE: https://t.co/OnFMtpwHnB Explore the findings at the link in this post.